Jove
Visualize
Contact Us

Related Concept Videos

Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

78.6K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
78.6K
DNA Bacteriophages01:26

DNA Bacteriophages

1.2K
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
1.2K
Lysogenic Cycle of Bacteriophages00:43

Lysogenic Cycle of Bacteriophages

68.3K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
68.3K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Viral Replication: Lysogenic Cycle01:16

Viral Replication: Lysogenic Cycle

2.0K
The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
2.0K
Viral Replication: Lytic Cycle01:20

Viral Replication: Lytic Cycle

2.0K
Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization and host range associating factors of Staphylococcus aureus bacteriophage PBSA08; Using Australian MRSA reference set.

International journal of antimicrobial agents·2026
Same author

In vitro activity of recently introduced Gram-positive-specific antimicrobial agents against Australian methicillin-resistant Staphylococcus aureus isolates.

Pathology·2026
Same author

Microbial Ecological Signatures Predict Pathogen Emergence and Multidrug Resistance in Cystic Fibrosis Airways up to a Year in Advance.

medRxiv : the preprint server for health sciences·2026
Same author

Attitudes to phage therapy among Australian infectious diseases physicians.

International journal of antimicrobial agents·2025
Same author

Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Surveillance Outcome Program (GnSOP) Bloodstream Infection Annual Report 2023.

Communicable diseases intelligence (2018)·2025
Same author

Phage Therapy in Korea: A Prescribers' Survey of Attitudes Amongst Korean Infectious Diseases Specialists Towards Phage Therapy.

Infection & chemotherapy·2024
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Mar 1, 2026

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings
07:22

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings

Published on: August 19, 2021

3.5K

Formulating and stabilising therapeutic phages: A review.

Eleni Siafakas1, Hien T T Duong2, Jonathan R Iredell3

  • 1Sydney Pharmacy School, University of Sydney, Sydney, NSW, Australia; Centre for Infectious Diseases and Microbiology, Westmead Institute for Medical Research, Sydney, NSW, Australia.

International Journal of Antimicrobial Agents
|February 27, 2026
PubMed
Summary

Bacteriophages (phages) are a promising antibiotic alternative, but poor shelf-stability hinders their use. This review explores factors affecting phage viability, aiming to improve formulation and storage for therapeutic applications.

Keywords:
BacteriophagesColloidsExcipientsNon-ionic formulationsProtein stability

More Related Videos

Understanding the Impact of Temperate Bacteriophages on Their Lysogens Through Transcriptomics
09:23

Understanding the Impact of Temperate Bacteriophages on Their Lysogens Through Transcriptomics

Published on: January 5, 2024

2.7K
Using Phage Display to Develop Ubiquitin Variant Modulators for E3 Ligases
06:30

Using Phage Display to Develop Ubiquitin Variant Modulators for E3 Ligases

Published on: August 27, 2021

3.7K

Related Experiment Videos

Last Updated: Mar 1, 2026

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings
07:22

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings

Published on: August 19, 2021

3.5K
Understanding the Impact of Temperate Bacteriophages on Their Lysogens Through Transcriptomics
09:23

Understanding the Impact of Temperate Bacteriophages on Their Lysogens Through Transcriptomics

Published on: January 5, 2024

2.7K
Using Phage Display to Develop Ubiquitin Variant Modulators for E3 Ligases
06:30

Using Phage Display to Develop Ubiquitin Variant Modulators for E3 Ligases

Published on: August 27, 2021

3.7K

Area of Science:

  • Microbiology
  • Biotechnology
  • Pharmaceutical Sciences

Background:

  • Bacteriophages (phages) show potential as alternatives to antibiotics against resistant bacteria.
  • Current limitations in phage therapy commercialization stem from poor shelf-stability of phage preparations.
  • A lack of standardized formulation approaches exists due to phage diversity and varied storage methods.

Purpose of the Study:

  • To review existing literature on factors influencing the shelf-stability of therapeutic phages.
  • To identify knowledge gaps in phage formulation and stabilization strategies.
  • To guide future research toward improving phage preparation longevity.

Main Methods:

  • Literature review integrating protein and biotherapeutic formulation data.
  • Examination of effects of container materials, buffers, salt/ions, pH, temperature, polymers, surfactants, and semi-solid formulations.
  • Analysis of phage viability loss mechanisms.

Main Results:

  • Shelf-stability is phage-dependent, influenced by various formulation and storage parameters.
  • Mechanisms of viability loss include surface adsorption, colloidal instability, aggregation, and structural/functional compromise.
  • Diverse factors like container type, pH, temperature, and excipients significantly impact phage stability.

Conclusions:

  • Standardized formulation protocols are needed to enhance phage therapy's clinical viability.
  • Further research is required to optimize phage stabilization for large-scale therapeutic use.
  • Addressing formulation challenges is crucial for realizing the full potential of phage therapy.